Delivery Order SPE2DB24D2003-SPE2DB25FXMA7
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) to support federal medical procurement needs. This non-competitive delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction under a larger contract vehicle. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,484.58 to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5ML on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract represents a pharmaceutical supply delivery to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and falls under a delivery order contract type,...
- The Defense Logistics Agency awarded a delivery order valued at $18,365.68 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $21,401.45 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $29,333.15 to AmerisourceBergen Drug Corp for Menquadfi vial 0.5ML on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively bid with no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $7,264.50 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) with a firm fixed price arrangement. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $15,903.80 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5ML) with a ceiling value of $8,254.21 under a firm fixed-price contract type. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside delivery order issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,905.80 to AmerisourceBergen Drug Corp for Menquadfi vial 0.5mL pharmaceutical products on June 5, 2025, with completion targeted for June 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5mL) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, reflects a competitively awarded transaction under the company's broader pharmaceutical supply relationship with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...